share_log

Zhejiang Runyang New Material Technology's (SZSE:300920) Shareholders May Want To Dig Deeper Than Statutory Profit

Zhejiang Runyang New Material Technology's (SZSE:300920) Shareholders May Want To Dig Deeper Than Statutory Profit

潤陽科技(SZSE:300920)的股東可能希望深入了解超過法定盈利
Simply Wall St ·  2024/11/08 06:51

The market shrugged off Zhejiang Runyang New Material Technology Co., Ltd.'s (SZSE:300920) solid earnings report. We think that investors might be worried about some concerning underlying factors.

市場對潤陽科技(SZSE:300920)的穩健收入報告毫不在意。我們認爲投資者可能擔心一些令人擔憂的潛在因素。

big
SZSE:300920 Earnings and Revenue History November 7th 2024
深交所:300920 盈利和營業收入歷史 2024年11月7日

How Do Unusual Items Influence Profit?

不尋常項目如何影響利潤?

For anyone who wants to understand Zhejiang Runyang New Material Technology's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥3.4m worth of unusual items. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. Which is hardly surprising, given the name. If Zhejiang Runyang New Material Technology doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.

對於任何想要理解潤陽科技盈利情況的人來說,重要的是要注意,在過去的十二個月中,法定利潤因價值340萬人民幣的異常項目而增加。雖然我們喜歡看到利潤的增長,但當異常項目對利潤的貢獻較大時,我們往往會更加謹慎。當我們分析全球絕大多數上市公司時,我們發現顯著的異常項目往往不會重複。這並不令人驚訝,畢竟它的名字。如果潤陽科技不再看到這一貢獻重複,那麼在其他條件不變的情況下,我們預計其利潤在當前年度會下降。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Zhejiang Runyang New Material Technology.

注意:我們始終建議投資者檢查資產負債表實力。單擊這裏查看我們對潤陽科技資產負債表分析。

Our Take On Zhejiang Runyang New Material Technology's Profit Performance

我們對潤陽科技的盈利表現的看法

We'd posit that Zhejiang Runyang New Material Technology's statutory earnings aren't a clean read on ongoing productivity, due to the large unusual item. Therefore, it seems possible to us that Zhejiang Runyang New Material Technology's true underlying earnings power is actually less than its statutory profit. The good news is that, its earnings per share increased by 31% in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you want to do dive deeper into Zhejiang Runyang New Material Technology, you'd also look into what risks it is currently facing. Be aware that Zhejiang Runyang New Material Technology is showing 2 warning signs in our investment analysis and 1 of those can't be ignored...

我們認爲潤陽科技的法定收益並不能準確反映其持續生產力,因爲存在較大的異常項目。 因此,我們認爲潤陽科技的真正潛在盈利能力實際上可能低於其法定利潤。 好消息是,其每股盈利在過去一年中增長了31%。 本文的目標是評估我們在多大程度上可以依賴法定收益來反映公司的潛力,但還有很多其他因素需要考慮。如果你想深入了解潤陽科技,還需要關注其當前面臨的風險。請注意,在我們的投資分析中,潤陽科技顯示出2個警告信號,其中1個不容忽視……

This note has only looked at a single factor that sheds light on the nature of Zhejiang Runyang New Material Technology's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

本報告只關注了一個因素,揭示了潤陽科技利潤的本質。但還有很多其他方法可以幫助你了解一家公司。一些人認爲高股本回報率是優質業務的良好標誌。因此,你可能希望查看這份免費的高股本回報率公司彙總或這份高內部持股的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論